May 19, 2020 / 03:40PM GMT
Navin Cyriac Jacob - UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap Pharmaceutic
Hello. Welcome to Day 2 of the UBS Global Healthcare Conference. My name is Navin Jacob. I'm a senior analyst covering large cap pharmaceuticals and some mid-cap biotech.
Our next presentation of fireside chat is with Bristol-Myers Squibb. It's my pleasure to have with me Chris Boerner, Chief Commercial Officer; as well as Samit Hirawat, Chief Medical Officer.
Thank you, both Chris and Samit, for joining us today.
Christopher S. Boerner - Bristol-Myers Squibb Company - Executive VP & Chief Commercialization Officer
It's our pleasure.
Questions and Answers:
Navin Cyriac Jacob - UBS Investment Bank, Research Division - Equity Research Analyst of Specialty Pharmaceuticals and Large Cap PharmaceuticPerfect. Well, let's -- we can't escape COVID, obviously. So maybe we'll just start off with a few questions there.
Chris, given that Bristol is